Display ad
HomeHealthHealth careJury clears Sterigenics in second trial

Jury clears Sterigenics in second trial

“We believe the jury’s verdict in this matter reflects the jury’s careful consideration and understanding of the science and other evidence presented at trial. Sterigenics remains committed to our mission of Safeguarding Global Health,” Sterigenics mentioned in a press release. “As we have done consistently throughout our history, we will continue to operate in compliance with applicable rules and regulations to ensure the safety of our employees, the communities in which we operate and patients around the world.”

Fornek’s is the second case introduced in opposition to Sterigenics that has concluded. More than 700 instances are nonetheless pending in opposition to the corporate, a lot of which happened after a research carried out by the U.S. Environmental Protection Agency in 2018 discovered that folks within the surrounding space confronted excessive most cancers dangers linked to Sterigenics.

Download Modern Healthcare’s app to stay informed when industry news breaks.

By distinction, in September, a unique jury found Sterigenics liable for inflicting most cancers in one other Willowbrook resident, Sue Kamuda, and ordered the corporate to pay her $363 million.

A subsidiary of Ohio-based Sotera Health, Sterigenics makes use of a chemical often called ethylene oxide to sterilize medical tools. The Willowbrook plant closed in September 2019.

Sotera’s inventory value surged on the day the most recent verdict was revealed. Shares are up 20% over the previous 5 days.

This story first appeared in our sister publication, Crain’s Chicago Business.

RELATED ARTICLES

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular